Our data clearly establish that the co-expression of apelin and APJ by pancreatic tumor cells fosters tumor growth, whereas loss of the apelin receptor dramatically reduces the tumor burden in murine orthotopic xenograft experiments. The gene discussed is APLN; the disease is neoplasm.